Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Wilcox

Surgery Colorado Springs, CO Medical Doctor

NPI 1750359642 CMS profile 125065

6965 Tutt Blvd Ste 200, Ste 245, Colorado Springs, CO 80923

Open in the dashboard

General payments

$31,904

222 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Wilcox of Colorado Springs, CO is reported in the CMS Open Payments database as having received $31,904 across 222 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,108 11
2024 General $11,165 42
2023 General $8,482 73
2022 General $3,665 31
2021 General $398 7
2020 General $1,398 12
2019 General $4,689 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Wilcox
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Robert Wilcox were reported at $2,108. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Robert Wilcox Surgery median Middle half National median
2019 $4,689 $253 $82–$1,521 $163
2020 $1,398 $131 $40–$706 $114
2021 $398 $168 $50–$904 $132
2022 $3,665 $224 $76–$1,218 $149
2023 $8,482 $253 $82–$1,255 $160
2024 $11,165 $279 $90–$1,381 $164
2025 $2,108 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $22,131 125 payments
  2. Intuitive Surgical, Inc. $4,468 27 payments
  3. Medical Device Business Services, Inc. $2,895 23 payments
  4. Ethicon US, LLC $634 16 payments
  5. Novo Nordisk Inc $576 8 payments
  6. Covidien LP $232 3 payments
  7. ReShape Lifesciences Inc. $202 3 payments
  8. Rhythm Pharmaceuticals, Inc. $137 2 payments
  9. W. L. Gore & Associates, Inc. $121 1 payment
  10. CONMED Corporation $93 1 payment
  11. Other $417 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,280 7 payments
  2. Travel and Lodging $9,572 60 payments
  3. Food and Beverage $7,052 154 payments
  4. Education $1,000 1 payment
Products named General payments · program years 2019–2025
  1. Signia $16,288 69 payments
  2. Da Vinci Surgical System $4,468 27 payments
  3. LigaSure $4,019 49 payments
  4. ECHELON FLEX Stapler $2,230 20 payments
  5. LINX Reflux Management System $1,016 12 payments
  6. STRATAFIX $990 10 payments
  7. HARMONIC Product Family $990 10 payments
  8. Echelon Flex $267 5 payments
  9. Wegovy $205 2 payments
  10. BIO-A Tissue Reinforcement $121 1 payment
  11. Other $732 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$17,422

Medicare's payments for the services billed

Medicare patients

30

Average age 65

Services billed

102

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 53%
Diabetes 43%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Wegovy
  • Novo Nordisk Inc $97
$97 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

222 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record